155 results found.

Prevention & Control Clinical Trial using Rivaroxaban (Xarelto, BAY59-7939); Aspirin; Aspirin placebo; Rivaroxaban placebo; Pantoprazole

Bayer - Recruiting 18 years or older.
- A Randomized Controlled Trial of Rivaroxaban for the Prevention of Major Cardiovascular Events in Patients With Coronary or Peripheral Artery Disease (COMPASS - Cardiovascular OutcoMes for People Using Anticoagulation StrategieS).
Rivaroxaban (Xarelto, BAY59-7939); Aspirin; Aspirin placebo; Rivaroxaban placebo; Pantoprazole

Acute Coronary Syndrome With ST Elevation on Electrocardiogram, A Clinical Trial

Niguarda Hospital - Recruiting 18 years to 80 years.
- Evaluation of Tryptase as a Biomarker of Coronary Heart Disease.

Hypercholesterolemia Clinical Trial using Evolocumab (AMG 145); Placebo

Amgen - Recruiting 18 years or older.
- A Randomized, Double-Blind, Multi-center, Placebo-controlled, Parallel-group Study to Determine the Effects of Evolocumab (AMG 145) Treatment on Atherosclerotic Disease Burden as Measured by Intravascular Ultrasound in Subjects Undergoing Coronary Catheterization..
Evolocumab (AMG 145); Placebo

Coronary Artery Disease Clinical Trial using Diagnostic Cardiac Imaging

Ohio State University - Recruiting 18 years or older.
- EXACT-COST: Exercise CMR's Accuracy for Cardiovascular Stress Testing-Comparative Effectiveness of Stress Tests.
Diagnostic Cardiac Imaging

Coronary Artery Disease, or Acute Coronary Syndrome Clinical Trial using Ticagrelor 180mg; Prasugrel 10mg; Ticagrelor 90mg

University of Florida - Recruiting 18 years to 74 years.
- Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor: The SWAP (SWitching Anti Platelet)-3 Study.
Ticagrelor 180mg; Prasugrel 10mg; Ticagrelor 90mg

Acute Renal Failure, Kidney Disease, or Coronary Artery Disease Clinical Trial using IV isotonic saline; IV isotonic bicarbonate; N-acetylcysteine; Placebo

Department of Veterans Affairs - Recruiting 18 years or older.
- CSP #578 - Prevention of Serious Adverse Outcomes Following Angiography.
IV isotonic saline; IV isotonic bicarbonate; N-acetylcysteine; Placebo

Coronary Artery Disease Clinical Trial using PCI with IVUS guidance; PCI without IVUS guidance

Yonsei University - Recruiting 20 years to 79 years.
- Impact of IntraVascular UltraSound Guidance on Outcomes of Xience Prime Stents in Long Lesions (IVUS-XPL Study).
PCI with IVUS guidance; PCI without IVUS guidance

Colorectal Cancer, Breast Cancer, Coronary Heart Disease, or Diab Clinical Trial using risk assessment survey; decision support for providers for prevention based on risk

Brigham and Women's Hospital - Recruiting 18 years to 75 years.
- Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care.
risk assessment survey; decision support for providers for prevention based on risk

Coronary Artery Disease Clinical Trial using Adenosine stress dynamic CT perfusion

Yonsei University - Recruiting 40 years to 80 years.
- .
Adenosine stress dynamic CT perfusion

Coronary Artery Disease Clinical Trial using Prasugrel; Ticagrelor

University of Florida - Recruiting 18 years to 74 years.
- A Pharmacodynamic Study Comparing Prasugrel Versus Ticagrelor in Patients With Coronary Artery Disease Undergoing PCI With CYP2C19 Loss-of-function Genotypes: A Feasibility Study With Point-of-care Pharmacodynamic and Genetic Testing.
Prasugrel; Ticagrelor

Coronary Artery Disease, Myocardial Ischemia, Coronary Disease, H Clinical Trial using eSVS Mesh

Kips Bay Medical, Inc. - Recruiting 21 years or older.
- Post-market Study to Evaluate Post-implant Patency Rates of the eSVS Mesh in the Treatment of Saphenous Vein Graphs During Coronary Artery Bypass Grafting Versus Saphenous Vein Grafts Without the eSVS Mesh Via Coronary Angiography and Duplex Ultra-Sonography Results.
eSVS Mesh

Coronary Arteriosclerosis, or Non ST Segment Elevation Acute Coro Clinical Trial using OrbusNeich R stentT; Everolimus Eluting Stent (EES)

OrbusNeich - Recruiting 20 years or older.
- Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt (Japan-USA HARMONEE): Assessment of a Novel DES Platform For Percutaneous Coronary Revascularization in Patients With Ischemic Coronary Disease and NSTEMI Acute Coronary Syndrome.
OrbusNeich R stentT; Everolimus Eluting Stent (EES)

Coronary Artery Disease, or Aortic Stenosis Clinical Trial using Real-time 3-dimensional DynaCT

New York University School of Medicine - Recruiting 18 years or older.
- Aortic Valve and Root Measurements Under Real-Time 3-Dimensional Visualization During Angiography.
Real-time 3-dimensional DynaCT

Coronary Artery Disease, or Atherosclerosis Clinical Trial

InfraReDx - Recruiting N/A or older.
- The Lipid-Rich Plaque (LRP) Study.

Atrial Fibrillation, or Coronary Artery Disease Clinical Trial using This is an observational study.

East and North Hertfordshire NHS Trust - Recruiting 18 years or older.
- Assessment of Thrombotic Status in Patients at Risk of Cardiovascular Thrombosis.
This is an observational study.

Coronary Artery Disease and Cardiac Anatomy, Patients Undergoing Clinical Trial using Relaxation Music

University Health Network, Toronto - Recruiting 18 years or older.
- Relaxation Music to Lower Heart Rate Prior to Cardiac CT.
Relaxation Music

Heart Diseases, Cardiovascular Diseases, or 3 Vessel Coronary Art Clinical Trial using Coronary stent; Multi Slice Computed Tomography; instantaneous wave-free ratio; Fractional flow reserve; Intravascular Ultrasound

ECRI bv - Recruiting 21 years or older.
- A Single-arm Trial to Evaluate the Effectiveness of PCI of de Novo 3-vessel Disease Applying the SYNTAX Score II With Pressure Wire Functional Assessment and IVUS Guidance, Using an Everolimus-eluting Stent With Biodegradable Abluminal Coating.
Coronary stent; Multi Slice Computed Tomography; instantaneous wave-free ratio; Fractional flow reserve; Intravascular Ultrasound

Coronary Artery Disease Clinical Trial using Angioshield

Neograft Technologies, Incorporated - Recruiting 18 years to 80 years.
- First-In-Human Study to Demonstrate the Preliminary Safety and Efficacy of the Angioshield System to Provide Mechanical Support for Vein Grafts Used in CABG Surgery.
Angioshield

Coronary Artery Disease Clinical Trial using Ticagrelor

Hellenic Cardiovascular Research Society - Recruiting 18 years to 79 years.
- A Single Center Phase II Assessor -Blinded RaNdomised Active Controlled Parallel-Group Trial to COmpare Ticagrelor Versus Clopidogrel on the REduction of ArteriaL STiffness and Wave Reflections in Patients With CoronarY Artery Disease. The NOVELTY Study.
Ticagrelor

Coronary Artery Disease Clinical Trial

National Taiwan University Hospital - Recruiting 20 years to 75 years.
- Using Non-invasive Near Infra-red Spectroscopy to Measure the Regional Tissue Perfusion in Patients Receiving Off-pump Coronary Artery Bypass Graft Surgery.

Coronary Disease Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Prospective Evaluation of New Techniques in Radiation Reduction for Cardiovascular Computed Tomographic Angiography.

Stable Angina Clinical Trial using Coronary angioplasty

Imperial College London - Recruiting 18 years to 85 years.
- Defining a Gold Standard for Ischaemia: Effects of Interventional Revascularisation Versus Optimum Medical Therapy on Exercise Capacity in Patients With Stable Coronary Artery Disease.
Coronary angioplasty

Coronary Artery Disease Clinical Trial using Colchicine; Placebo

New York University School of Medicine - Recruiting 18 years or older.
- Anti-inflammatory Effects of Colchicine in Patients Undergoing Percutaneous Coronary Intervention.
Colchicine; Placebo

Coronary Artery Disease Clinical Trial using Randomized left versus right radial artery approach

New York University School of Medicine - Recruiting 18 years or older.
- Effect of Left Versus Right Radial Artery Access on Radiation Exposure in Patients With Predictors of Potential Trans-radial Access Failure.
Randomized left versus right radial artery approach

Kidney Transplant Recipient Clinical Trial using 64-slice Multidetector coronary CT angiography

Yonsei University - Recruiting 40 years or older.
- .
64-slice Multidetector coronary CT angiography

Coronary Artery Disease, or Atrial Fibrillation Clinical Trial using 6 weeks; 6 months

Deutsches Herzzentrum Muenchen - Recruiting 18 years or older.
- Intracoronary Stenting and Antithrombotic Regimen: Testing of a Six-week Versus a Six-month Clopidogrel Treatment Regimen in Patients With Concomitant Aspirin and Oral Anticoagulant Therapy Following Drug-eluting Stenting.
6 weeks; 6 months

Coronary Artery Disease, Mitral Valve Regurgitation, Mitral Valve Clinical Trial using CEP MAGNA MITRAL PERICARDIAL BIOPROSTHESES

Edwards Lifesciences - Recruiting 18 years or older.
- Carpentier-Edwardsr Perimount Magnar Mitral Pericardial Bioprostheses Models 7000/7000 TFX and Carpentier-Edwardsr Perimount Magnar Mitral EaseT Pericardial Bioprostheses Models 7200TFX and 7300/7300TFX.
CEP MAGNA MITRAL PERICARDIAL BIOPROSTHESES

Cardiovascular Diseases, Coronary Disease, Coronary Artery Diseas Clinical Trial using cardiac catheterization; coronary artery bypass graft surgery; percutaneous coronary intervention; Lifestyle; Medication

New York University School of Medicine - Recruiting 21 years or older.
- International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA).
cardiac catheterization; coronary artery bypass graft surgery; percutaneous coronary intervention; Lifestyle; Medication

Coronary Artery Disease Clinical Trial

Global Genomics Group, LLC - Recruiting 18 years to 90 years.
- Genetic Loci and the Burden of Atherosclerotic Lesions.

Atherosclerosis, or Coronary Artery Disease Clinical Trial

University Hospital Inselspital, Berne - Recruiting 18 years or older.
- Innate Human Collateral Supply to Different Vascular Regions.

Coronary Artery Disease Clinical Trial using Adenosine

Vanderbilt University - Recruiting 18 years to 65 years.
- Ticagrelor and Adenosine Uptake. Phase II Study Comparing the Effects of Ticagrelor vs Dipyridamole on Adenosine Uptake.
Adenosine

Angina, or Coronary Artery Disease Clinical Trial using Exercise training

Norwegian University of Science and Technology - Recruiting N/A or older.
- Exercise-training Before Coronary Artery Bypass Graft (CABG).
Exercise training

Coronary Artery Disease Clinical Trial using Serelaxin; Placebo

Novartis - Recruiting 18 years or older.
- A Multicenter, Double Blind, Randomized, Parallel Group, Placebo-controlled Study to Evaluate the Effects of Intravenous Serelaxin Infusion on Micro- and Macrovascular Function in Patients With Coronary Artery Disease.
Serelaxin; Placebo

Coronary Artery Disease Clinical Trial using Vascular Access Device; Standard Manual Compression

Borgess Research Institute - Recruiting 18 years to 85 years.
- A Randomized Controlled Trial to Assess Safety and Efficacy of AXERA (Device Name) 2 Access System Compared to Manual Compression.
Vascular Access Device; Standard Manual Compression

Coronary Artery Disease Clinical Trial using Invasive coronary evaluation (Deferred); Invasive coronary evaluation (Acute)

Rigshospitalet, Denmark - Recruiting 18 years or older.
- Entire Danish Initiative To ImrpOve Revascularization Strategies (EDITORS) - A Randomised Evaluation of Clinical Outcome After Acute or Deferred Invasive Intervention Integrated With MDCT Imaging in Patients With Acute Coronary Syndromes.
Invasive coronary evaluation (Deferred); Invasive coronary evaluation (Acute)

Ischemic Heart Disease Clinical Trial using coronary artery bypass grafting with administration of autologous bone marrow stem cells

St. Petersburg State Pavlov Medical University - Recruiting 18 years to 80 years.
- Influence of the Administration of Autologous Bone Marrow Mononuclear Cells for the Duration of Functioning Aorto-coronary Bypass Grafts in the Surgical Treatment of Coronary Heart Disease.
coronary artery bypass grafting with administration of autologous bone marrow stem cells

Coronary Artery Disease Clinical Trial

University of Texas Southwestern Medical Center - Recruiting N/A or older.
- Multicenter Registry of Chronic Total Occlusion Interventions.

Metabolic Syndrome, or Coronary Artery Disease Clinical Trial

Ankara University - Recruiting 18 years to 80 years.
- Angiotensin Converting Enzyme Inhibitor Therapy and Periprocedural Myocardial Infarction in Patients With Metabolic Syndrome.

Coronary Heart Disease Clinical Trial using SMT-enhanced Cardiac Rehabilitation; Standard Cardiac Rehabilitation

Duke University - Recruiting 35 years or older.
- Enhancing Standard Cardiac Rehabilitation With Stress Management Training in Patients With Heart Disease.
SMT-enhanced Cardiac Rehabilitation; Standard Cardiac Rehabilitation

Coronary Artery Disease, or High Bleeding Risk Patients Clinical Trial using Pantera Lux Drug Eluting Balloon

Biotronik France - Recruiting 18 years or older.
- Proposing an Alternative Treatment to patiEnts for Whom DES Implantation is Not Indicated, Thanks to Pantera LUX Drug Eluting Balloon.
Pantera Lux Drug Eluting Balloon

Coronary Artery Disease, Aortic Stenosis, Aortic Insufficiency, M Clinical Trial using cardioPAT cell saver

Rigshospitalet, Denmark - Recruiting 18 years or older.
- CardioPAT Project - Reducing the Need for Allogenic Blood Transfusion After On-pump Cardiac Surgery With Intra- and Postoperative Use of a New Device: a Randomized Trial.
cardioPAT cell saver

Coronary Heart Disease Clinical Trial

China National Center for Cardiovascular Diseases - Recruiting 18 years or older.
- The China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) Prospective Study of Acute Myocardial Infarction.

Coronary Heart Disease Clinical Trial

China National Center for Cardiovascular Diseases - Recruiting 18 years or older.
- The China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) Prospective Study of Revascularization in Patients With Three-vessel Coronary Heart Disease.

Coronary Artery Occlusive Disease Clinical Trial using Pravastatin 40mg; Rosuvastatin

Yonsei University - Recruiting 20 years to 80 years.
- .
Pravastatin 40mg; Rosuvastatin

Coronary Artery Disease Clinical Trial using iFR; FFR

Imperial College London - Recruiting 18 years to 90 years.
- Prospective, Multi-center, Double Blind, Randomised Study to Test the Safety of Deferral of Stenting in Physiological Non-significant Lesions in a Clinical Population of Intermediate Stenoses Using iFR and FFR.
iFR; FFR

Coronary Artery Disease Clinical Trial using Exercise Facilitator Intervention

University of Ottawa Heart Institute - Recruiting 18 years or older.
- Ecologically Optimizing Exercise Maintenance in Men and Women Post-Cardiac Rehabilitation: A Randomized Controlled Trial of Efficacy With Economics.
Exercise Facilitator Intervention

Coronary Artery Disease, Coronary Disease, Myocardial Ischemia, H Clinical Trial using CorPath-assisted Percutaneous Coronary Intervention

Corindus Inc. - Recruiting 18 years or older.
- A Post-Market Registry for the Evaluation of the CorPath 200 System Effectiveness in Percutaneous Coronary Interventions.
CorPath-assisted Percutaneous Coronary Intervention

CORONARY ARTERY DISEASE Clinical Trial using caffeine; not caffeine

University of Roma La Sapienza - Recruiting 18 years to 80 years.
- 'Potential Effect of Acute and Chronic Caffeine Administration on Platelet Reactivity in Patient With Coronary Artery Disease on Dual Antiplatelet Therapy'.
caffeine; not caffeine

Coronary Artery Disease, or Diabetes Mellitus Type 2 Clinical Trial using Glucagon-Like-Peptide-1/Regadenoson/Perflutren Lipid Microsphere

Mayo Clinic - Recruiting 40 years to 60 years.
- Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes: Modulation by Glucagon-Like-Peptide-1.
Glucagon-Like-Peptide-1/Regadenoson/Perflutren Lipid Microsphere

Coronary Artery Disease, Myocardial Ischemia, or Heart Diseases Clinical Trial using MICS CABG; OPCABG; ONCABG; Octopusr Nuvo, Starfishr Non-Sternotomy, ThoraTrakr; Starfishr, Octopusr, Clearviewr blower, ClearViewr Shunt

Vitebsk Regional Clinical Hospital - Recruiting 18 years to 80 years.
- Comparative Effectiveness of the Minimally Invasive Coronary Artery Bypass Grafting (MICS CABG) Versus Off Pump (OPCABG) and on Pump Coronary Artery Bypass Grafting (ONCABG) in Patients With Multi-vessel Coronary Disease.
MICS CABG; OPCABG; ONCABG; Octopusr Nuvo, Starfishr Non-Sternotomy, ThoraTrakr; Starfishr, Octopusr, Clearviewr blower, ClearViewr Shunt

Heart Failure, or Coronary Artery Disease Clinical Trial using Radioisotope

University of Ottawa Heart Institute - Recruiting 18 years or older.
- Optimization of Cardiac Iodine-123 Meta-iodobenzylguanidine (123I-mIBG) SPECT Imaging.
Radioisotope

Coronary Artery Disease, or Angioplasty, Balloon Clinical Trial using Balloon angioplasty

Asan Medical Center - Recruiting 20 years or older.
- Evaluation of Effectiveness and Safety of Drug-Eluting Balloon in Routine Clinical Practice; A Multicenter Prospective Observational Cohort Study.
Balloon angioplasty

Cardiovascular Disease, or Coronary Artery Calcification Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 45 years to 65 years.
- ClinSeq: A Large-Scale Medical Sequencing Clinical Research Pilot Study.

Type-2 Diabetes Mellitus, or Coronary Artery Disease Clinical Trial using Ticagrelor + Aspirin; Clopidogrel + Aspirin

Mount Sinai School of Medicine - Recruiting 18 years to 75 years.
- Comparative Study of the Antithrombotic Effects of Ticagrelor and Clopidogrel in Type 2 Diabetic Patients.
Ticagrelor + Aspirin; Clopidogrel + Aspirin

Obstructive Coronary Artery Disease, or Coronary Artery Disease Clinical Trial using rosuvastatin

Mount Sinai School of Medicine - Recruiting 18 years or older.
- YELLOW II Study: Reduction in Coronary Yellow Plaque, Lipids and Vascular Inflammation by Aggressive Lipid Lowering.
rosuvastatin

Obstructive Coronary Artery Disease, Coronary Arteriosclerosis, o Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 45 years.
- A Pilot Dosing Study for Gadofosveset Trisodium (Ablavar) for Coronary Magnetic Resonance Angiography (MRA).

Heart Disease, Ischemic Heart Disease, Coronary Artery Disease, o Clinical Trial using Cell Therapy

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 85 years.
- Preliminary Assessment of Direct Intra-Myocardial Injection of Autologous Bone Marrow-derived Stromal Cells on Patients Undergoing Revascularization for CAD With Depressed Left Ventricular Function.
Cell Therapy

Coronary Artery Disease, Myocardial Ischemia, Coronary Disease, H Clinical Trial using Custodiol HTK; Cold Blood Cardioplegia

William Beaumont Hospitals - Recruiting 18 years or older.
- Custodiol-HTK Solution as a Cardioplegic Agent- A Prospective Non-Inferiority Randomized Clinical Trial.
Custodiol HTK; Cold Blood Cardioplegia

Coronary Artery Disease Clinical Trial

Yonsei University - Recruiting 19 years or older.
- Prospective Registry for Patients Undergoing Coronary Angiography and Percutaneous Coronary Intervention in Gangwon Province.

Coronary Heart Disease, Unstable Angina, or Blood Stasis Syndrome Clinical Trial using Xuesaitong soft capsule; Xuesaitong soft capsule Placebo

Guang'an Men Hospital - Recruiting 30 years to 75 years.
- The Analysis of Blood Stasis Syndromeand of Coronary Heart Disease Related MicroRNA Genomics and Target Gene Regulatory Networks.
Xuesaitong soft capsule; Xuesaitong soft capsule Placebo

Heart Failure, or Coronary Artery Disease Clinical Trial using Rivaroxaban; Placebo; Standard of care for heart failure and coronary artery disease

Janssen Research & Development, LLC - Recruiting 18 years to 95 years.
- A Randomized, Double-blind, Event-driven, Multicenter Study Comparing the Efficacy and Safety of Oral Rivaroxaban With Placebo for Reducing the Risk of Death, Myocardial Infarction or Stroke in Subjects With Chronic Heart Failure and Significant Coronary Artery Disease Following a Hospitalization for Exacerbation of Heart Failure.
Rivaroxaban; Placebo; Standard of care for heart failure and coronary artery disease

Coronary Artery Disease, or Cardiac CT Clinical Trial

Kumamoto University - Recruiting 20 years to 90 years.
- Evaluation of Cardiac CT Appropriateness at Second-generation 320-row CT With 0.275-sec Gantry Rotation Speed.

Coronary Artery Disease, or Coronary Restenosis Clinical Trial using Percutaneous coronary intervention

Biotronik AG - Recruiting 18 years or older.
- BIOLUX RCT - Clinical Performance of the Pantera LUX Paclitaxel Releasing Balloon Versus the Drug Eluting Orsiro Hybrid Stent System in Patients With In-stent Restenosis - a Randomized Controlled Trial.
Percutaneous coronary intervention

Coronary Artery Disease, Acute Myocardial Infarction With ST-segm Clinical Trial using Early discharge; Standard discharge

Municipal Hospital Ostrava - Recruiting 18 years to 75 years.
- Official Title Verification of the Safety of Early Discharge (Within 72 Hours) in Low Risk Patients After Acute ST-segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention. Open Randomized Study..
Early discharge; Standard discharge

Coronary Artery Disease Clinical Trial using Aspirin or thienopyridine; Aspirin and thienopyridine

Associations for Establishment of Evidence in Interventions - Recruiting 20 years to 80 years.
- Nobori Dual Antiplatelet Therapy as Appropriate Duration..
Aspirin or thienopyridine; Aspirin and thienopyridine

Diabetes, Type I, Diabetes, Type II, Angina, or Coronary Artery D Clinical Trial using Ranolazine; Placebo Pill

Brigham and Women's Hospital - Recruiting 18 years to 90 years.
- Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Patients With Diabetes and Suspected or Known Coronary Artery Disease.
Ranolazine; Placebo Pill

Coronary Artery Disease, or Noninvasive Plaque Characterization Clinical Trial

University Hospital Heidelberg - Recruiting 18 years to 90 years.
- Comprehensive 'Bio-Imaging' Using Quantitative Coronary Plaque Composition Assessment and the High-sensitive Troponin T for the Prediction of Cardiac Outcomes..

Coronary Artery Disease Clinical Trial using Gadobutrol (Gadovist, BAY86-4875)

Bayer - Recruiting 18 years or older.
- Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis.
Gadobutrol (Gadovist, BAY86-4875)

Coronary Artery Disease Clinical Trial

University of Sao Paulo - Recruiting 20 years to 80 years.
- Study of Coffee and Its Influence on the Heart in Normal People, Those With Coronary Artery Disease and Diabetics..

Heart Failure, Cardiomyopathy, Dilated, or Coronary Disease Clinical Trial using Resynchronization using a transeptal approach; Resynchronization using a coronary sinus approach

University Hospital, Bordeaux - Recruiting 18 years or older.
- Randomized Comparison of Endocardial Versus Epicardial - From the Coronary Sinus - Left Ventricular Pacing for Resynchronization in Heart Failure..
Resynchronization using a transeptal approach; Resynchronization using a coronary sinus approach

Angioplasty, Cardiovascular Disease, Chronic Coronary Occlusion, Clinical Trial using XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS)

Abbott Vascular - Recruiting 18 years or older.
- Evaluate the Continued Safety and Effectiveness of the XIENCE PRIME EECSS in a Cohort of Real-world Patients Receiving the XIENCE PRIME EECSS During Commercial Use..
XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS)

Coronary Artery Disease Clinical Trial using Cangrelor; Clopidogrel; Prasugrel

The Medicines Company - Recruiting 18 years to 75 years.
- A Study of the Transition From Cangrelor to Clopidogrel or Prasugrel in Patients With Coronary Artery Disease..
Cangrelor; Clopidogrel; Prasugrel

Coronary Artery Disease Clinical Trial using CBT

National Taiwan University Hospital - Recruiting 30 years to 70 years.
- Development and Evaluation of a Web-based Group Cognitive-behavioral Therapy Program for Coronary Artery Heart Disease Patients.
CBT

Coronary Artery Disease Clinical Trial using BuMA; EXCEL

Sino Medical Sciences Technology Inc. - Recruiting 18 years or older.
- A Prospective, Multicenter, RAndomized, CoNtrolled, Study Comparing the Safety and Efficacy Between BuMA eG Based BioDegradable Polymer Stent and EXCEL Biodegradable Polymer Sirolimus-eluting Stent in 'ReAl-World' Practice (PANDA-III).
BuMA; EXCEL

Coronary Arteries Disease Clinical Trial using PRO-Kinetic Energy Stent

Biotronik, Inc. - Recruiting 18 years or older.
- The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent.
PRO-Kinetic Energy Stent

Coronary Artery Disease Clinical Trial using EXCEL-II biodegradable polymer sirolimus-eluting stent

JW Medical Systems Ltd - Recruiting 18 years to 75 years.
- A Prospective Multicenter Single-Arm Observational Registry Study to Assess the Safety and Efficacy of EXCEL-II With Sirolimus Eluting Stent for the Treatment of Patients With de Novo Coronary Artery . (CREDIT-III Trial).
EXCEL-II biodegradable polymer sirolimus-eluting stent

Coronary Artery Disease Clinical Trial using quit smoking for a 2 weeks period

University of Roma La Sapienza - Recruiting 18 years to 90 years.
- 'Impact of Cigarette Smoking on Platelet Reactivity in Patients With Acute Coronary Syndromes on Dual Antiplatelet Therapy With P2Y12 Inhibitors' - Trial COPTER -.
quit smoking for a 2 weeks period

Coronary Artery Disease, or Chronic Kidney Disease Clinical Trial

Chang Gung Memorial Hospital - Recruiting 18 years to 85 years.
- Clinical Feature and Outcome of Angiographic Coronary Artery Disease in Chronic Kidney Disease Patients.

Coronary Artery Disease, or Myocardial Infarction Clinical Trial using Primary Percutaneous Coronary Intervention

Karolinska Institutet - Recruiting 18 years or older.
- Reduction in Infarct Size by Remote Per-postconditioning in Patients With ST-elevation Myocardial Infarction in Stockholm (RECOND).
Primary Percutaneous Coronary Intervention

Coronary Artery Disease Clinical Trial using CTA+CTP guided treatment strategy; CTA guided treatment strategy

Rigshospitalet, Denmark - Recruiting 50 years or older.
- Myocardial Perfusion 320 MDCT Guided Treatment Strategy for the Clinical Management of Patient With Recent Acute-onset Chest Pain. A Randomized Controlled Trial.
CTA+CTP guided treatment strategy; CTA guided treatment strategy

Type 2 Diabetes, Coronary Artery Disease, or Left Ventricular Mas Clinical Trial using alpha-lipoic acid

Wuhan General Hospital of Guangzhou Military Command - Recruiting 40 years to 70 years.
- Alpha-lipoic Acid Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease.
alpha-lipoic acid

Cardiovascular Diseases, Coronary Artery Disease, Myocardial Isch Clinical Trial

Medical Care Center Prof. Mathey, Prof. Schofer, Ltd. - Recruiting 18 years to 75 years.
- Postmarketing Surveillance Registry to Monitor Everolimus-eluting Bioresorbable Vascular Scaffold Following Rotational Atherectomy for the Treatment of Complex Coronary Lesions - The ASSURE ROT Registry.

Coronary Artery Disease Clinical Trial

Rigshospitalet, Denmark - Recruiting 55 years or older.
- Prospective International Study of Coronary Substraction Using 320 Row-detector CT.

Coronary Artery Disease Clinical Trial

Associations for Establishment of Evidence in Interventions - Recruiting 20 years or older.
- Japan Study of Distal Evaluation of Functional Significance of Intra-arterial Stenosis Narrowing Effect.

Coronary Artery Disease Clinical Trial using CT coronary angiography and computational fluid dynamics

Seoul National University Hospital - Recruiting 18 years or older.
- Non-invasive Functional Assessment of Coronary Stenoses Using CT Coronary Angiography and Computational Fluid Dynamics.
CT coronary angiography and computational fluid dynamics

Cardiovascular Disease, Myocardial Infarction, Thrombus, or Prima Clinical Trial using Bioresorbable vascular scaffold; Durable polymer everolimus-eluting metallic stent

Deutsches Herzzentrum Muenchen - Recruiting 18 years or older.
- Intracoronary Scaffold Assessment a Randomised Evaluation of Absorb in Myocardial Infarction (ISAR-Absorb MI) A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction.
Bioresorbable vascular scaffold; Durable polymer everolimus-eluting metallic stent

Rheumatoid Arthritis Clinical Trial using Exercise

Capital District Health Authority, Canada - Recruiting 20 years to 75 years.
- The Effects of a 12-week Cardiovascular Rehabilitation Exercise Program on Inflammatory Markers and Traditional Coronary Artery Disease Risk Factors in Patients With Rheumatoid Arthritis.
Exercise

Type 2 Diabetes Mellitus, or Cardiovascular Disease Clinical Trial using Saxagliptin

Duke University - Recruiting 45 years to 75 years.
- Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Saxagliptin

Coronary Heart Disease Clinical Trial using Tetraspan; acetated Ringer`s solution

Haukeland University Hospital - Recruiting 18 years to 80 years.
- Ringer`s Acetat Versus Balanced Hydroxyethyl-starch as Primesolution in the Heart-lung Maschine During Cardio-pulmonary-bypass. Postoperatively Fluid Balance and Cardiac Function.
Tetraspan; acetated Ringer`s solution

Coronary Artery Disease, Valvular Diseases, or Vascular Diseases Clinical Trial

University of California, Davis - Recruiting 18 years or older.
- Factors That Affect the Outcomes of Cardiothoracic and Vascular Surgery.

Angina Pectoris, or Myocardial Infarction Clinical Trial using VEGF-D gene transfer

Kuopio University Hospital - Recruiting 30 years to 80 years.
- Endocardial VEGF-D Gene Therapy for the Treatment of Severe Coronary Heart Disease - A Phase 1 Single-blinded Placebo-controlled Phase 1 Clinical Trial.
VEGF-D gene transfer

Coronary Artery Disease Clinical Trial using Resolute Integrity Stent

Medtronic Vascular - Recruiting 18 years or older.
- Resolute Integrity US A Postapproval Study of the Medtronic ResoluteT Integrity Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries With a Reference Vessel Diameter of 2.25 mm to 4.2 mm.
Resolute Integrity Stent

Coronary Artery Disease, or Behavioral Clinical Trial

University of Arizona - Recruiting 21 years or older.
- Typical Daily Emotions, Ischemia and Repolarization in Coronary Artery Disease.

Coronary Artery Disease, or Ischemic Disease Clinical Trial using gekoTM

Lawson Health Research Institute - Recruiting 18 years or older.
- Peripheral Stimulation Device to Improve Coronary Flow Reserve in Coronary Artery Disease.
gekoTM

Coronary Artery Disease Clinical Trial

Portuguese Society of Cardiology - Recruiting 18 years or older.
- Portuguese Registry on Interventional Cardiology.

Coronary Artery Disease, or Coronary Stenosis Clinical Trial

Maastricht University Medical Center - Recruiting 18 years or older.
- Maastricht Biomarker CT Study. Relation Between Cardiovascular Biomarkers and Coronary Atherosclerosis in Patients Undergoing Multi Detector Cardiac Computed Tomography..

Coronary Artery Disease Clinical Trial using CT/MR; Catheterization

Charite University, Berlin, Germany - Recruiting 30 years or older.
- Coronary Artery Disease Management Using Multislice Computed Tomography and Magnetic Resonance Imaging.
CT/MR; Catheterization

Coronary Artery Disease Clinical Trial using PCI with Svelte Acrobat; PCI with other BMS

Svelte Medical Systems Europe - Recruiting 18 years or older.
- Acrobat Coronary Stent System Effectiveness European Study (European Multicenter Effectiveness Randomized Study of Svelte Medical Systems Acrobat Stent on a Wire Compared to Other BMS PCI in de Novo Coronary Lesions) ACES Trial.
PCI with Svelte Acrobat; PCI with other BMS

Hypercholesterolemia, or Coronary Artery Disease Clinical Trial using Combination therapy with Lipitor [Atorvastatin] and Zetia [Ezetimibe]; Lipitor (Atorvastatin) monotherapy

Kumamoto University - Recruiting 30 years to 85 years.
- Plaque REgression With Cholesterol Absorption Inhibitor or Synthesis Inhibitor Evaluated by IntraVascular UltraSound.
Combination therapy with Lipitor [Atorvastatin] and Zetia [Ezetimibe]; Lipitor (Atorvastatin) monotherapy

Angina Pectoris, or Coronary Heart Disease Clinical Trial using Computer Tomography Angiography

University of Edinburgh - Recruiting 18 years to 75 years.
- Role of Multidetector Computed Tomography in the Diagnosis and Management of Patients Attending a Rapid Access Chest Pain Clinic.
Computer Tomography Angiography

Coronary Artery Disease Clinical Trial using Promus Element, Boston Scientific Corporation; Nobori, Terumo Corporation (Japan)

Ajou University School of Medicine - Recruiting 20 years or older.
- Comparison of Biolimus-eluting Biodegradable Polymer, Everolimus-eluting and Sirolimus-eluting Coronary Stents.
Promus Element, Boston Scientific Corporation; Nobori, Terumo Corporation (Japan)

Coronary Artery Disease Clinical Trial using Ticagrelor; Clopidogrel

Rapid City Regional Hospital, Inc - Recruiting 18 years or older.
- A Single Center, Randomized, Open Label, Multiple Dose, Crossover Study of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in American Indian Patients With Stable Coronary Artery Disease.
Ticagrelor; Clopidogrel

Ischemic Heart Disease Clinical Trial using FFR guided PCI; OCT guided PCI

Catholic University of the Sacred Heart - Recruiting 18 years or older.
- FFR or OCT Guidance to RevasculariZe Intermediate Coronary Stenosis Using Angioplasty.
FFR guided PCI; OCT guided PCI

Coronary Artery Disease Clinical Trial using Atorvastatin

Indiana University - Recruiting 21 years to 85 years.
- Effects of Short Term, High Dose Atorvastatin Therapy on Periprocedural Myonecrosis and Platelet Inhibition After PCI.
Atorvastatin

Fluid Responsiveness Predictability Clinical Trial using Fluid loading (Voluven)

Yonsei University - Recruiting 20 years or older.
- .
Fluid loading (Voluven)

Coronary Artery Disease Clinical Trial using LC-1000; LC-2000; Q10-150; Q10-300; Placebo

Taichung Veterans General Hospital - Recruiting 20 years to 90 years.
- .
LC-1000; LC-2000; Q10-150; Q10-300; Placebo

Coronary Artery Disease, Cerebral Vascular Disease, Peripheral Ar Clinical Trial

New York University School of Medicine - Recruiting 21 years or older.
- Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients.

Coronary Artery Disease, or Drug-eluting Stent Clinical Trial

Associations for Establishment of Evidence in Interventions - Recruiting 20 years to 85 years.
- A Prospective Multicenter Post Approval Study to Evaluate the Long-term Safety and Efficacy of the Resolute Integrity in the Japanese All-comers Patients With Coronary Artery Disease.

Coronary Artery Disease Clinical Trial

University of Roma La Sapienza - Recruiting 18 years or older.
- PROgenitor Cells Role in Restenosis and Progression of Coronary ATherosclerosis After Percutaneous Coronary Intervention (PROCREATION) Study.

Coronary Artery Disease Clinical Trial

CardioDx - Recruiting 45 years to 75 years.
- Effect of Exercise Stress Testing on Peripheral Gene Expression Using CORUST CAD Diagnostic Test.

Coronary Artery Disease Clinical Trial

Johannes Gutenberg University Mainz - Recruiting 18 years or older.
- Mainz Registry of Flow-mediated Constriction.

Coronary Heart Disease Clinical Trial using Clopidogrel 75mg; Clopidogrel 150mg; Aspirin 100mg; Cilostazol 100mg

Cardiovascular Institute & Fuwai Hospital - Recruiting 18 years to 75 years.
- Investigator Initiated Prospective Study to Investigate the Best Anti-platelet Treatment in High Thrombotic Risk PCI Patients..
Clopidogrel 75mg; Clopidogrel 150mg; Aspirin 100mg; Cilostazol 100mg

Coronary Heart Disease Clinical Trial using RSD; PCI

The First Hospital of Nanjing Medical University - Recruiting 18 years to 75 years.
- Safety and Effectiveness Study of Percutaneous Catheter-based Renal Sympathetic Denervation as a Method of Secondary Prevention for Patients After Percutaneous Coronary Intervention..
RSD; PCI

Coronary Artery Disease Clinical Trial using adenosine; regadenoson; Adenosine

St. Louis University - Recruiting 18 years or older.
- Utilization of Lexiscan (Regadenoson)in the Cardiac Catheterization Lab to Achieve Maximal Hyperemia for Coronary Physiologic Assessment With Fractional Flow Reserve.
adenosine; regadenoson; Adenosine

Coronary Artery Disease Clinical Trial using Implantation of everolimus-eluting bioresorbable vascular scaffold stent; Implantation of everolimus-eluting stents; Implantation of biolimus-eluting stents

University of Freiburg - Recruiting 18 years to 70 years.
- Comparison of Everolimus- and Biolimus-Eluting Stents With Everolimus-Eluting Bioresorbable Vascular Scaffold Stents.
Implantation of everolimus-eluting bioresorbable vascular scaffold stent; Implantation of everolimus-eluting stents; Implantation of biolimus-eluting stents

Coronary Artery Disease Clinical Trial using Coronary stenting; Ticagrelor; Clopidogrel; Prasugrel

Johannes Gutenberg University Mainz - Recruiting 18 years to 75 years.
- Effects of Clopidogrel vs Prasugel vs Ticagrelor on Endothelial Function, Inflammatory and Oxidative Stress Parameters and Platelet Function in Patients Undergoing Coronary Artery Stenting. A Randomised, Prospective Study..
Coronary stenting; Ticagrelor; Clopidogrel; Prasugrel

Coronary Artery Disease, or Cardiovascular Disease Clinical Trial

Oslo University Hospital - Recruiting 18 years or older.
- Markers of Coronary Artery Disease During Exercise Testing.

Coronary Artery Disease Clinical Trial

University of Alberta - Recruiting 18 years or older.
- Assessment of Patients With Suspected CAD: What is the Best Initial Imaging Strategy? Cardiac Computed Tomographic Angiography,(CCTA) vs Stress Echocardiography (SE) vs SPECT.

Coronary Artery Disease Clinical Trial using Rosuvastatin calcium 40mg; Rosuvastatin calcium10mg

CardioVascular Research Foundation, Korea - Recruiting 18 years or older.
- Effect of High-Dose and Low-Dose Statin for Coronary Plaque Modification.
Rosuvastatin calcium 40mg; Rosuvastatin calcium10mg

Coronary Artery Disease Clinical Trial using follow-up coronary angiography; Clinical follow-up

Kyoto University, Graduate School of Medicine - Recruiting 20 years or older.
- Randomized Evaluation of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention Trial.
follow-up coronary angiography; Clinical follow-up

Type 2 Diabetes, Coronary Artery Disease, Hypertension, or Dyslip Clinical Trial using intensive control; standard control

Kyoto University, Graduate School of Medicine - Recruiting 20 years or older.
- Intensive Blood Pressure and LDL Lowering for Better Survival and Cardiovascular Outcome in Diabetic Patients With Coronary Artery Disease: Randomized Controlled Trial.
intensive control; standard control

Coronary Artery Disease Clinical Trial using Varenicline tartrate tablets; Counseling and psychosocial support

General Hospital of Chinese Armed Police Forces - Recruiting 18 years to 79 years.
- Influence of Varenicline on the Antiplatelet Action of Clopidogrel : the Randomized, Open-label VACL (Varenicline Clopidogrel) Study.
Varenicline tartrate tablets; Counseling and psychosocial support

Coronary Artery Disease Clinical Trial using XIENCE PRIMETM everolimus-eluting coronary stent

Seoul National University Hospital - Recruiting 18 years or older.
- .
XIENCE PRIMETM everolimus-eluting coronary stent

Coronary Artery Disease Clinical Trial

Cardiocentro Ticino - Recruiting N/A or older.
- Incremental Value of Signal Processed Surface Electrocardiography (IECG) for Detecting Ischemic Heart Disease: Comparison With Computed Tomography Coronary Angiography (CTCA).

Chronic Stable Angina, Coronary Artery Disease, Atrial Fibrillati Clinical Trial using ranolazine; placebo

Cardiovascular Consultants of Nevada - Recruiting 35 years or older.
- Safety of Amiodarone and Ranolazine Together in Patients With Stable Angina.
ranolazine; placebo

End Stage Renal Disease, or Myocardial Microvascular Disease Clinical Trial using Invasive FFR + CFR measurements are performed during coronary angiography using a pressure guide wire

Hospices Civils de Lyon - Recruiting 18 years or older.
- Detection and Outcomes of Myocardial Microvascular Disease in Patients With End Stage Renal Disease.
Invasive FFR + CFR measurements are performed during coronary angiography using a pressure guide wire

Coronary Artery Disease Clinical Trial using Bivalirudin; Heparin

Stony Brook University - Recruiting 18 years or older.
- STATUS-PCI: Stable Angina Therapy With Angiomaxr or Unfractionated Heparin for patientS Undergoing Percutaneous Coronary Intervention.
Bivalirudin; Heparin

Coronary Artery Disease Clinical Trial using Pitavastatin 1 mg daily or 4 mg daily

Juntendo University Hospital - Recruiting 20 years to 79 years.
- Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy With Pitavastatin in Coronary Artery Disease (REAL-CAD).
Pitavastatin 1 mg daily or 4 mg daily

Schizophrenia, Schizoaffective Disorder, Major Depression, Bipola Clinical Trial using Eicosapentaenoic acid (omega-3 fatty acid); Placebo

University of Pittsburgh - Recruiting 18 years or older.
- CAD Risk in Schizophrenia: Effect of Omega-3 Fatty Acid Supplementation.
Eicosapentaenoic acid (omega-3 fatty acid); Placebo

Coronary Artery Disease Clinical Trial using Robotic-assisted Coronary Surgical Revascularization; PCI- Drug Eluting Stents

Lawson Health Research Institute - Recruiting 30 years to 85 years.
- Same Procedure Cardiac Hybrid Surgery in a Specialty Built OR-- A Pilot Study.
Robotic-assisted Coronary Surgical Revascularization; PCI- Drug Eluting Stents

Coronary Artery Disease Clinical Trial using Radi pressure wire (pressure wire assessment)

University Hospital Southampton NHS Foundation Trust. - Recruiting 18 years or older.
- Does Routine Pressure Wire Assessment Influence Management Strategy at Coronary Angiography for Diagnosis of Chest Pain?.
Radi pressure wire (pressure wire assessment)

Coronary Artery Disease, Acute Coronary Syndrome, Genetic Resista Clinical Trial

Biotronik France - Recruiting 18 years or older.
- Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment.

Coronary Artery Disease Clinical Trial using atorvastatin; atorvastatin plus ezetimibe

Shanghai Jiao Tong University School of Medicine - Recruiting 18 years to 75 years.
- Same Lipid Lowering by Atorvastatin Versus Atorvastatin Plus Ezetimibe on Coronary Plaque Progression.
atorvastatin; atorvastatin plus ezetimibe

Old Myocardial Infarction, Chronic Myocardial Ischemia, or Left V Clinical Trial using bone marrow mononuclear cells injection; placebo intramyocardial injection

Chinese PLA General Hospital - Recruiting 18 years to 75 years.
- A Prospective,Randomized, Placebo-Controlled Study of Intramyocardial Injection of Autologous Bone-Marrow Mononuclear Cells in Patients With Severe, Chronic Ischemic Heart Disease Undergoing Coronary Bypass Surgery.
bone marrow mononuclear cells injection; placebo intramyocardial injection

Heart Disease, Ischemic, or Atherosclerosis, Coronary Clinical Trial using adenosine

Northwestern University - Recruiting 18 years or older.
- Comprehensive Evaluation of Ischemic Heart Disease Using MRI.
adenosine

Diabetes Mellitus, or Coronary Artery Disease Clinical Trial using Acarbose

Taichung Veterans General Hospital - Recruiting 18 years to 70 years.
- Screen of Diabetes Mellitus by Oral Glucose Tolerance Test in Subjects Receiving Catheterization or Multi-detector Computed Tomography (MDCT) for Coronary Artery Disease.
Acarbose

Coronary Artery Disease, Atherosclerosis, Thrombosis, or Acute My Clinical Trial using Drug eluting balloon; Bare metal stent; Drug eluting stent

UMC Utrecht - Recruiting 18 years to 80 years.
- Randomized Comparison of Drug Eluting Balloon/Bare Metal Stent Versus Drug Eluting Stent Versus Bare Metal Stent for the Treatment of Patients With Acute ST-elevation Myocardial Infarction.
Drug eluting balloon; Bare metal stent; Drug eluting stent

Coronary Artery Disease Clinical Trial using Promus Element; Promus

A.O. Ospedale Papa Giovanni XXIII - Recruiting 18 years or older.
- Optical Coherence Tomography for EVERolimus Eluting STent (OCTEVEREST).
Promus Element; Promus

Coronary Heart Disease, or Diabetes Mellitus Clinical Trial using Polymer-based sirolimus-eluting stent(Cypher stent ) and Polymer-free paclitaxel-eluting stent (YinYi stent)

Harbin Medical University - Recruiting 18 years to 75 years.
- Comparison of Diabetes Mellitus and Non-diabetes Mellitus Patients for Surface Coverage After Two Types of Drug-eluting Stent Implantation (A Pilot Study).
Polymer-based sirolimus-eluting stent(Cypher stent ) and Polymer-free paclitaxel-eluting stent (YinYi stent)

Coronary Artery Disease, or Acute Coronary Syndrome Clinical Trial using Intrepide Trapidil eluting stent; Taxus drug eluting stent

Clearstream Technologies Ltd. - Recruiting 18 years or older.
- OCT Evaluation of Stent Struts Re-endothelization in Patients With Acute Coronary Syndromes: a Comparison of the IntrepideT Stent vs. TaxusT.
Intrepide Trapidil eluting stent; Taxus drug eluting stent

Coronary Artery Disease Clinical Trial using Minimally invasive direct coronary artery bypass; PCI-Drug eluting stents; Off-pump coronary artery bypass

China National Center for Cardiovascular Diseases - Recruiting 18 years to 80 years.
- Comparison of 'One-stop' Hybrid Coronary Revascularization Versus Off-pump Coronary Artery Bypass for the Treatment of Multi-vessel Coronary Artery Disease.
Minimally invasive direct coronary artery bypass; PCI-Drug eluting stents; Off-pump coronary artery bypass

Coronary Artery Lesion Clinical Trial using coronary dual source computed tomography (DSCT); myocardial single photon emission computed topography (SPECT)

Assistance Publique Hopitaux De Marseille - Recruiting 18 years or older.
- Dual Source Computed Tomography (DSCT) During Injection of Dipyridamole : a New Technique for Myocardial Ischemia Assessment.
coronary dual source computed tomography (DSCT); myocardial single photon emission computed topography (SPECT)

Coronary Artery Disease Clinical Trial using Xience V Everolimus Eluting Coronary Stent System. Abbott Laboratories. Abbott Park, Illinois, U.S.A.

Spanish Society of Cardiology - Recruiting 18 years or older.
- Everolimus-Eluting Stent in the Treatment of Bifurcation Lesions: Comparison of Main Vessel Stent to Main Vessel and Side Branch Stent.
Xience V Everolimus Eluting Coronary Stent System. Abbott Laboratories. Abbott Park, Illinois, U.S.A.

Coronary Disease Clinical Trial using stent

CCRF Consulting Co., Ltd. - Recruiting 18 years to 75 years.
- Clinical Trial Program of a Medical Instrument Product.
stent

Coronary Artery Disease Clinical Trial using Taxus stent; Vision stent

Samsung Medical Center - Recruiting 18 years or older.
- Do Cobalt Chrome Stent and Paclitaxel-Eluting Stent Have Equivalent Clinical Result in Non-Complex Lesion? (COPE Study): Long-Term Follow-up Study.
Taxus stent; Vision stent

Coronary Artery Disease Clinical Trial

Fudan University - Recruiting N/A or older.
- CRP Gene Variants and Coronary Artery Disease in a Chinese Han Population.

Coronary Disease Clinical Trial using tube voltage

Deutsches Herzzentrum Muenchen - Recruiting 18 years or older.
- Prospective Randomized Trial On RadiaTion Dose Estimates Of CT AngIOgraphy In PatieNts Scanned With A 100kV Protocol.
tube voltage

Coronary Artery Disease, or Decision Making Clinical Trial using Decision Counseling Program (DCP); Coronary Artery Disease Decision Aid

Oslo University Hospital - Recruiting 18 years or older.
- Effects of a Decision Aid for Patients With Coronary Artery Disease on Cardiac Risk Factor Modification Behavior and Health Outcomes.
Decision Counseling Program (DCP); Coronary Artery Disease Decision Aid

Coronary Artery Disease Clinical Trial using 6R-BH4

University of Oxford - Recruiting 18 years or older.
- A Randomised, Placebo-Controlled Study of Two Doses of Oral 6R-BH4 on Vascular Function in Subjects With Coronary Artery Disease.
6R-BH4

Diabetes Mellitus, Hypertension, Dyslipidemia, Obesity, Cardiovas Clinical Trial using Intensive Education for Metabolic Syndrome Patients

Rajavithi Hospital - Recruiting 16 years or older.
- The Rajavithi Prospective Cohort Study on Community's Member Health (HPH-Cohort Study).
Intensive Education for Metabolic Syndrome Patients

Coronary Artery Disease Clinical Trial using sirolimus drug eluting coronary stent CypherT (Cordis Corp, Johnson & Johnson Co); paclitaxel polymer drug eluting stent Taxus LibertŠT (Boston Scientific, Natick MS); zotarolimus drug eluting coronary stent EndeavorT (Medtronic, Santa Rosa, CA); LibertŠ bare metal coronary stent LibertŠT BMS(Boston Scientific, Natick, MS)

A.O. Ospedale Papa Giovanni XXIII - Recruiting 18 years or older.
- In-Vivo Vascular Response of Sirolimus-,Paclitaxel- and Zotarolimus-Eluting Stents in Long Lesions Requiring Overlapping. A Prospective, Randomized, Controlled Study Using Optical Coherence Tomography.
sirolimus drug eluting coronary stent CypherT (Cordis Corp, Johnson & Johnson Co); paclitaxel polymer drug eluting stent Taxus LibertŠT (Boston Scientific, Natick MS); zotarolimus drug eluting coronary stent EndeavorT (Medtronic, Santa Rosa, CA); LibertŠ bare metal coronary stent LibertŠT BMS(Boston Scientific, Natick, MS)

Coronary Artery Disease Clinical Trial using PCI of bifurcated coronary lesions using sirolimus coated stents in modified T-Stenting -Technique

Heart Center Bad Krozingen - Recruiting 18 years or older.
- Prospective, Randomized, Single-Center Evaluation of the CypherT Sirolimus Eluting Coronary Stent System in the Treatment of Bifurcated Coronary Lesions.
PCI of bifurcated coronary lesions using sirolimus coated stents in modified T-Stenting -Technique

Congestive Heart Failure, Ischemic Cardiomyopathy, Coronary Arter Clinical Trial using Blue Egg Device

BioVentrix - Recruiting 18 years or older.
- A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart.
Blue Egg Device

Coronary Disease Clinical Trial using 24 hr Holter monitor

National Taiwan University Hospital - Recruiting 20 years or older.
- .
24 hr Holter monitor